Literature DB >> 27730284

Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: a systematic review.

Oleksa G Rewa1, Pierre-Marc Villeneuve2, Philippe Lachance2, Dean T Eurich3, Henry T Stelfox4, R T Noel Gibney2, Lisa Hartling5, Robin Featherstone5, Sean M Bagshaw2.   

Abstract

OBJECTIVES: Renal replacement therapy is increasingly utilized in the intensive care unit (ICU), of which continuous renal replacement therapy (CRRT) is most common. Despite CRRT being a relatively invasive and resource intensive technology, there remains wide practice variation in its application. This systematic review appraised the evidence for quality indicators (QIs) of CRRT care in critically ill patients.
DESIGN: A comprehensive search strategy was developed and performed in five citation databases (Medline, Embase, CINAHL, Cochrane Library, and PubMed) and select grey literature sources. Two reviewers independently screened, selected, and extracted data using standardized forms. Each retrieved citation was appraised for quality using the Newcastle-Ottawa Scale (NOS) and Cochrane risk of bias tool. Data were summarized narratively.
MEASUREMENTS AND MAIN RESULTS: Our search yielded 8374 citations, of which 133 fulfilled eligibility. This included 97 cohort studies, 24 randomized controlled trials, 10 case-control studies, and 2 retrospective medical audits. The quality of retrieved studies was generally good. In total, 18 QIs were identified that were mentioned in 238 instances. Identified QIs were classified as related to structure (n = 4, 22.2 %), care processes (n = 9, 50.0 %), and outcomes (n = 5, 27.8 %). The most commonly mentioned QIs focused on filter lifespan (n = 98), small solute clearance (n = 46), bleeding (n = 30), delivered dose (n = 19), and treatment interruption (n = 5). Across studies, the definitions used for QIs evaluating similar constructs varied considerably. When identified, QIs were most commonly described as important (n = 144, 48.3 %), scientifically acceptable (n = 32, 10.7 %), and useable and/or feasible (n = 17, 5.7 %) by their primary study authors.
CONCLUSIONS: We identified numerous potential QIs of CRRT care, characterized by heterogeneous definitions, varying quality of derivation, and limited evaluation. Further study is needed to prioritize a concise inventory of QIs to measure, improve, and benchmark CRRT care for critically ill patients. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42015015530.

Entities:  

Keywords:  Continuous renal replacement therapy; Critical care; Dialysis; Effectiveness; Intensive care; Quality indicator

Mesh:

Year:  2016        PMID: 27730284     DOI: 10.1007/s00134-016-4579-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  28 in total

1.  Introduction and overview of the conceptual framework for a national quality measurement and reporting system.

Authors:  Elizabeth A McGlynn
Journal:  Med Care       Date:  2003-01       Impact factor: 2.983

2.  Evaluating the quality of medical care. 1966.

Authors:  Avedis Donabedian
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

3.  Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.

Authors:  Sean M Bagshaw; Kevin B Laupland; Paul J E Boiteau; Tomas Godinez-Luna
Journal:  J Crit Care       Date:  2005-06       Impact factor: 3.425

4.  An empirical comparison of key statistical attributes among potential ICU quality indicators.

Authors:  Sydney E S Brown; Sarah J Ratcliffe; Scott D Halpern
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

Review 5.  The first international consensus conference on continuous renal replacement therapy.

Authors:  John A Kellum; Ravindra L Mehta; Derek C Angus; Paul Palevsky; Claudio Ronco
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

6.  Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.

Authors:  Eric A J Hoste; Sean M Bagshaw; Rinaldo Bellomo; Cynthia M Cely; Roos Colman; Dinna N Cruz; Kyriakos Edipidis; Lui G Forni; Charles D Gomersall; Deepak Govil; Patrick M Honoré; Olivier Joannes-Boyau; Michael Joannidis; Anna-Maija Korhonen; Athina Lavrentieva; Ravindra L Mehta; Paul Palevsky; Eric Roessler; Claudio Ronco; Shigehiko Uchino; Jorge A Vazquez; Erick Vidal Andrade; Steve Webb; John A Kellum
Journal:  Intensive Care Med       Date:  2015-07-11       Impact factor: 17.440

7.  Temporal changes in incidence of dialysis-requiring AKI.

Authors:  Raymond K Hsu; Charles E McCulloch; R Adams Dudley; Lowell J Lo; Chi-yuan Hsu
Journal:  J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 10.121

8.  Intensity of renal support in critically ill patients with acute kidney injury.

Authors:  Paul M Palevsky; Jane Hongyuan Zhang; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Devasmita Choudhury; Kevin Finkel; John A Kellum; Emil Paganini; Roland M H Schein; Mark W Smith; Kathleen M Swanson; B Taylor Thompson; Anitha Vijayan; Suzanne Watnick; Robert A Star; Peter Peduzzi
Journal:  N Engl J Med       Date:  2008-05-20       Impact factor: 91.245

9.  Transition From Heparin to Citrate Anticoagulation for Continuous Renal Replacement Therapy: Safety, Efficiency, and Cost.

Authors:  David Gutierrez-Bernays; Matthew Ostwald; Chris Anstey; Victoria Campbell
Journal:  Ther Apher Dial       Date:  2016-01-14       Impact factor: 1.762

10.  Stakeholder Engagement to Identify Priorities for Improving the Quality and Value of Critical Care.

Authors:  Henry T Stelfox; Daniel J Niven; Fiona M Clement; Sean M Bagshaw; Deborah J Cook; Emily McKenzie; Melissa L Potestio; Christopher J Doig; Barbara O'Neill; David Zygun
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

View more
  25 in total

Review 1.  Focus on acute kidney injury 2017.

Authors:  Miet Schetz; John Prowle
Journal:  Intensive Care Med       Date:  2018-09-05       Impact factor: 17.440

Review 2.  Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury.

Authors:  Sean M Bagshaw; Michael Darmon; Marlies Ostermann; Fredric O Finkelstein; Ron Wald; Ashita J Tolwani; Stuart L Goldstein; David J Gattas; Shigehiko Uchino; Eric A Hoste; Stephane Gaudry
Journal:  Intensive Care Med       Date:  2017-03-13       Impact factor: 17.440

Review 3.  The intensive care medicine agenda on acute kidney injury.

Authors:  Peter Pickkers; Marlies Ostermann; Michael Joannidis; Alexander Zarbock; Eric Hoste; Rinaldo Bellomo; John Prowle; Michael Darmon; Joseph V Bonventre; Lui Forni; Sean M Bagshaw; Miet Schetz
Journal:  Intensive Care Med       Date:  2017-01-30       Impact factor: 17.440

Review 4.  How To Prescribe And Troubleshoot Continuous Renal Replacement Therapy: A Case-Based Review.

Authors:  Javier A Neyra; Lenar Yessayan; Melissa L Thompson Bastin; Keith M Wille; Ashita J Tolwani
Journal:  Kidney360       Date:  2020-12-14

Review 5.  Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions.

Authors:  Alain Combes; Daniel Brodie; Nadia Aissaoui; Thomas Bein; Gilles Capellier; Heidi J Dalton; Jean-Luc Diehl; Stefan Kluge; Daniel F McAuley; Matthieu Schmidt; Arthur S Slutsky; Samir Jaber
Journal:  Intensive Care Med       Date:  2022-08-09       Impact factor: 41.787

Review 6.  Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Yasushi Tsujimoto; Sho Miki; Hiroki Shimada; Hiraku Tsujimoto; Hideto Yasuda; Yuki Kataoka; Tomoko Fujii
Journal:  Cochrane Database Syst Rev       Date:  2021-09-14

7.  The Effectiveness of a Specialized Nursing Team Intervention in the Unplanned Interruption of Continuous Renal Replacement Therapy.

Authors:  Zhen Lu; Yanyan Hong; Yali Tian; Li Zhang; Yan Li
Journal:  Iran J Public Health       Date:  2022-03       Impact factor: 1.479

Review 8.  Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.

Authors:  Enzo Vásquez Jiménez; Samaya J Anumudu; Javier A Neyra
Journal:  Nephron       Date:  2021-02-04       Impact factor: 2.847

9.  Quality Improvement Goals for Acute Kidney Injury.

Authors:  Kianoush Kashani; Mitchell Howard Rosner; Michael Haase; Andrew J P Lewington; Donal J O'Donoghue; F Perry Wilson; Mitra K Nadim; Samuel A Silver; Alexander Zarbock; Marlies Ostermann; Ravindra L Mehta; Sandra L Kane-Gill; Xiaoqiang Ding; Peter Pickkers; Azra Bihorac; Edward D Siew; Erin F Barreto; Etienne Macedo; John A Kellum; Paul M Palevsky; Ashita Jiwat Tolwani; Claudio Ronco; Luis A Juncos; Oleksa G Rewa; Sean M Bagshaw; Theresa Ann Mottes; Jay L Koyner; Kathleen D Liu; Lui G Forni; Michael Heung; Vin-Cent Wu
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 8.237

10.  Analysis of Survival After Initiation of Continuous Renal Replacement Therapy in a Surgical Intensive Care Unit.

Authors:  James M Tatum; Galinos Barmparas; Ara Ko; Navpreet Dhillon; Eric Smith; Daniel R Margulies; Eric J Ley
Journal:  JAMA Surg       Date:  2017-10-01       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.